,Indicator,NFHS_5,NFHS_4
1,Female population age 6 years and above who ever attended school (%),74.4,69.4
2,Population below age 15 years (%),20.2,21.8
3,"Sex ratio of the total population (females per 1,000 males)","1,102","1,077"
4,"Sex ratio at birth for children born in the last five years (females per 1,000 males)",872,"1,140"
5,Children under age 5 years whose birth was registered with the civil authority (%),98.4,96.9
6,Deaths in the last 3 years registered with the civil authority (%),90.0,na
7,Population living in households with electricity (%),99.3,97.5
8,Population living in households with an improved drinking-water source (%),96.8,97.4
9,Population living in households that use an improved sanitation facility(%),87.9,66.9
10,Households using clean fuel for cooking (%),86.1,51.1
11,Households using iodized salt (%),98.5,94.2
12,Households with any usual member covered under a health insurance/financing scheme (%),36.9,39.8
13,Children age 5 years who attended pre-primary school during the school year 2019-20 (%),(8.9),na
15,Women who are literate (%),82.0,na
16,Women with 10 or more years of schooling (%),51.3,45.6
18,Women age 20-24 years married before age 18 years (%),16.2,13.2
19,Births in the 5 years preceding the survey that are third or higher order (%),0.0,0.4
20,Women age 15-19 years who were already mothers or pregnant at the time of the survey (%),6.4,6.6
21,Women age 15-24 years who use hygienic methods of protection during their menstrual period (%),92.0,83.4
23,Any method (%),78.1,56.7
24,Any modern method (%),77.5,56.2
25,Female sterilization (%),62.1,51.1
26,Male sterilization (%),0.4,0.0
27,IUD/PPIUD (%),6.3,3.1
28,Pill (%),3.2,0.7
29,Condom (%),3.3,1.3
30,Injectables (%),0.8,0.0
32,Total unmet need(%),5.2,7.9
33,Unmet need for spacing (%),1.8,3.8
35,Health worker ever talked to female non-users about family planning (%),57.1,12.8
36,Current users ever told about side effects of current method (%),82.2,52.4
38,Mothers who had an antenatal check-up in the first trimester (%),67.6,72.4
39,Mothers who had at least 4 antenatal care visits (%),75.8,86.4
40,Mothers whose last birth was protected against neonatal tetanus (%),98.6,90.3
41,Mothers who consumed iron folic acid for 100 days or more when they were pregnant (%),50.1,38.8
42,Mothers who consumed iron folic acid for 180 days or more when they were pregnant (%),33.6,27.3
43,Registered pregnancies for which the mother received a Mother and Child Protection (MCP) card (%),97.8,96.5
45,Mothers who received postnatal care from a doctor/nurse/LHV/ANM/midwife/other health personnel within 2 days of delivery (%),92.6,68.3
46,Average out-of-pocket expenditure per delivery in a public health facility (Rs.),"3,421","4,493"
47,Children born at home who were taken to a health facility for a check-up within 24 hours of birth (%),*,*
49,Children who received postnatal care from a doctor/nurse/LHV/ANM/midwife/other health personnel within 2 days of delivery (%),86.1,na
51,Institutional births (%),100.0,97.3
52,Institutional births in public facility (%),71.7,57.2
53,Home births that were conducted by skilled health personnel (%),0.0,0.0
54,Births attended by skilled health personnel (%),97.1,96.5
55,Births delivered by caesarean section (%),41.8,32.8
56,Births in a private health facility that were delivered by caesarean section (%),71.6,51.8
57,Births in a public health facility that were delivered by caesarean section (%),30.0,21.0
60,Children age 12-23 months fully vaccinated based on information from either vaccination card or mother's recall (%),(96.8),(68.1)
61,Children age 12-23 months fully vaccinated based on information from vaccination card only (%),(94.3),(56.4)
62,Children age 12-23 months who have received BCG (%),(100.0),(97.8)
63,Children age 12-23 months who have received 3 doses of polio vaccine (%),(96.8),(82.2)
64,Children age 12-23 months who have received 3 doses of penta or DPT vaccine (%),(100.0),(84.6)
65,Children age 12-23 months who have received the first dose of measles-containing vaccine (MCV) (%),(100.0),(84.1)
66,Children age 24-35 months who have received a second dose of measles-containing vaccine (MCV) (%),(39.3),na
67,Children age 12-23 months who have received 3 doses of rotavirus vaccine (%),(8.7),na
68,Children age 12-23 months who have received 3 doses of penta or hepatitis B vaccine (%),(97.3),(66.2)
69,Children age 9-35 months who received a vitamin A dose in the last 6 months (%),91.7,87.0
70,Children age 12-23 months who received most of their vaccinations in a public health facility (%),(97.4),(89.0)
71,Children age 12-23 months who received most of their vaccinations in a private health facility (%),(2.6),(11.0)
73,Prevalence of diarrhoea in the 2 weeks preceding the survey (%),4.0,8.8
74,Children with diarrhoea in the 2 weeks preceding the survey who received oral rehydration salts (ORS) (%),*,*
75,Children with diarrhoea in the 2 weeks preceding the survey who received zinc (%),*,*
76,Children with diarrhoea in the 2 weeks preceding the survey taken to a health facility or health provider (%),*,*
77,Prevalence of symptoms of acute respiratory infection (ARI) in the 2 weeks preceding the survey (%),1.9,2.3
79,Children with fever or symptoms of ARI in the 2 weeks preceding the survey taken to a health facility or health provider (%),*,(81.9)
81,Children under age 3 years breastfed within one hour of birth (%),43.1,50.8
82,Children under age 6 months exclusively breastfed (%),*,*
83,Children age 6-8 months receiving solid or semi-solid food and breastmilk (%),*,*
84,Breastfeeding children age 6-23 months receiving an adequate diet  (%),(25.2),(0.0)
85,Non-breastfeeding children age 6-23 months receiving an adequate diet (%),*,*
86,Total children age 6-23 months receiving an adequate diet  (%),29.1,(4.6)
87,Children under 5 years who are stunted (height-for-age) (%),27.1,27.0
88,Children under 5 years who are wasted (weight-for-height) (%),15.2,19.1
89,Children under 5 years who are severely wasted (weight-for-height) (%),5.2,6.4
90,Children under 5 years who are underweight (weight-for-age) (%),23.8,26.4
91,Children under 5 years who are overweight (weight-for-height) (%),5.1,0.6
93,Women whose Body Mass Index (BMI) is below normal (BMI <18.5 kg/m) (%),11.1,18.4
94,Women who are overweight or obese (BMI ≥25.0 kg/m) (%),36.1,27.9
95,Women who have high risk waist-to-hip ratio (≥0.85) (%),57.0,na
97,Children age 6-59 months who are anaemic (<11.0 g/dl) (%),63.6,53.1
98,Non-pregnant women age 15-49 years who are anaemic (<12.0 g/dl) (%),42.0,47.5
99,Pregnant women age 15-49 years who are anaemic (<11.0 g/dl) (%),(47.0),(33.0)
100,All women age 15-49 years who are anaemic (%),42.2,47.0
101,All women age 15-19 years who are anaemic (%),34.2,43.7
104,Women - Blood sugar level - high (141-160 mg/dl)(%),6.6,na
105,Women - Blood sugar level - very high (>160 mg/dl)(%),8.4,na
106,Women - Blood sugar level - high or very high (>140 mg/dl) or taking medicine to control blood sugar level (%),16.3,na
108,Men - Blood sugar level - high (141-160 mg/dl)(%),8.8,na
109,Men - Blood sugar level - very high (>160 mg/dl) (%),9.1,na
110,Men - Blood sugar level - high or very high (>140 mg/dl) or taking medicine to control blood sugar level (%),18.7,na
113,Women - Mildly elevated blood pressure (Systolic 140-159 mm of Hg and/or Diastolic 90-99 mm of Hg) (%),15.7,na
114,Women - Moderately or severely elevated blood pressure (Systolic ≥160mm of Hg and/or Diastolic ≥100mm of Hg) (%),7.6,na
116,Women - Elevated blood pressure (Systolic ≥140 mm of Hg and/or Diastolic ≥90 mm of Hg) or taking medicine to control blood pressure (%),28.1,na
118,Men - Mildly elevated blood pressure (Systolic 140-159 mm of Hg and/or Diastolic 90-99 mm of Hg) (%),18.0,na
119,Men - Moderately or severely elevated blood pressure (Systolic ≥160mm of Hg and/or Diastolic ≥100mm of Hg) (%),8.0,na
121,Men - Elevated blood pressure (Systolic ≥140 mm of Hg and/or Diastolic ≥90 mm of Hg) or taking medicine to control blood pressure (%),29.5,na
123,Ever undergone a screening test for cervical cancer (%),0.0,na
124,Ever undergone a breast examination for breast cancer (%),0.0,na
125,Ever undergone an oral cavity examination for oral cancer (%),0.0,na
127,Women age 15 years and above who use any kind of tobacco (%),10.9,na
128,Men age 15 years and above who use any kind of tobacco (%),29.0,na
129,Women age 15 years and above who consume alcohol (%),1.0,na
130,Men age 15 years and above who consume alcohol (%),26.6,na
